Representation of the controlling shareholders of InteCure in a transaction to acquire control of Canndoc
Our firm represented Mr. Alex Rabinovich, the controlling shareholder of InterCure Ltd., in negotiations to acquire joint control of Canndoc Ltd., a company with an active license from the Ministry of Health to grow medical marijuana and distribute it to patients in Israel. Mr. Rabinovich is to provide InterCure with credit to finance the transaction, under which InterCure, traded on the Tel Aviv Stock Exchange, is to acquire 50% of the controlling share capital and approx. 40% of the ordinary share capital of Canndoc. Doron Hadas and Raya Lalazar from our firm represented Mr. Rabinovich.
For more details, please visit the article in Globes: